Johnson & Johnson Innovative Medicine

• Scalable biological-cognitive profiling for Alzheimer's disease in the population

  Jun 1, 2026

• Fitness in CLL

  Jan 21, 2026

• Noninvasive Screening for Elevated LVEDP and Health Status in Outpatients at Risk for Heart Failure

  Jul 18, 2025

• Association of relapse with all-cause mortality in adult patients with stable schizophrenia

  May 9, 2025

• A Biomarker Profile Reflective of Preserved Thymic Function Is Associated With Reduced Comorbidities in Aging People With HIV: An AGEhIV Cohort Analysis

  Mar 17, 2025

• Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer's disease

  Mar 4, 2025

• Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant

  Jun 12, 2024

• A systematic review of the effect of structured exercise on inflammation and body composition in inflammatory bowel disease

  May 25, 2023

• Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis

  May 2, 2019

• Medical comorbidity in complicated grief: Results from the HEAL collaborative trial

  Sep 20, 2017

Sources: api.crossref.org

• CSF and plasma lipid profiling predicts risk of cognitive impairment in cognitively unimpaired older adults

  Consulting or advice, Oct 1, 2026

• Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks

  Employment, Feb 19, 2026

• Temporal and Spatial Scales of Human Resting-State Cortical Activity across the Lifespan

  Employment, Jan 14, 2026

• Age modifies the association between sex and the plasma inflammatory proteome in treated HIV

  Fees or honoraria, Dec 9, 2025

• Prevalence and risk factors of cerebral microhemorrhages and superficial siderosis in cognitively unimpaired older adults: analysis from the CHARIOT-PRO SubStudy

  Employment, Aug 1, 2025

• Association of relapse with all-cause mortality in adult patients with stable schizophrenia

  Employment, May 9, 2025

• Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection

  Employment, Jan 30, 2025

Sources: europepmc.org, pubmed.ncbi.nlm.nih.gov